Dave Gancarz | SVP, Stakeholder Relations, Business Development & Corporate Strategy |
Robert Duggan | CEO & Executive Chairman |
Mahkam Zanganeh | CEO, President & Director |
Ankur Dhingra | CFO |
Allen Yang | Former Head, Clinical Development & Acting Chief Medical Officer |
Good morning, everyone, and welcome to the Summit Therapeutics Second Quarter 2023 Earnings Call. Please note that this call is being recorded. [Operator Instructions].
I would now like to turn today's call over to Dave Gancarz. Please go ahead.